Cholinergic system function and cognition in mild cognitive impairment.

Area of Science:

• Neuroscience
• Neurology
• Radiochemistry

Background:

• Cholinergic dysfunction is suspected in early neurodegeneration like mild cognitive impairment (MCI), but evidence remains inconclusive.
• Previous positron emission tomography (PET) studies on small samples explored links between cholinergic function and memory impairment.

Purpose of the Study:

• To investigate reduced cortical acetylcholine esterase (AChE) activity in mild cognitive impairment (MCI) patients.
• To correlate cerebral AChE activity with cognitive function in individuals with MCI.

Main Methods:

• Utilized N-"[(11)C]"methyl-4-piperidyl acetate (["11"]C]MP4A) PET tracer to measure in vivo cerebral AChE activity.
• Analyzed AChE activity in 21 controls and 17 MCI patients across standard atlas regions.
• Employed Principal Components Analysis (PCA) and correlation analysis with neuropsychological test results.

Main Results:

• MCI patients exhibited significantly reduced cortical AChE activity compared to controls, most notably in temporal regions.
• A principal component derived from regional AChE activity strongly correlated with verbal and nonverbal memory, language comprehension, and executive function.
• These findings suggest a link between cholinergic deficits and cognitive impairments in MCI.

Conclusions:

• Cholinergic dysfunction is an early hallmark of neurodegeneration, preceding dementia onset at the mild cognitive impairment (MCI) stage.
• The impact of cholinergic dysfunction, particularly in the temporal neocortex, is associated with impaired neuropsychological function in MCI.